Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.

× No keyword cloud information.

20 in total

Review 1. Does rituximab increase the incidence of infectious complications? A narrative review.

Authors: Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal: Int J Infect Dis Date: 2010-11-11 Impact factor: 3.623

2. Consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Authors: J S Smolen; E C Keystone; P Emery; F C Breedveld; N Betteridge; G R Burmester; M Dougados; G Ferraccioli; U Jaeger; L Klareskog; T K Kvien; E Martin-Mola; K Pavelka
Journal: Ann Rheum Dis Date: 2006-10-26 Impact factor: 19.103

Review 3. B cell-targeted therapy for rheumatoid arthritis: an update on the evidence.

Authors: R John Looney
Journal: Drugs Date: 2006 Impact factor: 9.546

4. [[Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins].

Authors: C Mühlhoff; M Megahed
Journal: Hautarzt Date: 2007-11 Impact factor: 0.751

Review 5. B cells as under-appreciated mediators of non-auto-immune inflammatory disease.

Authors: Barbara S Nikolajczyk
Journal: Cytokine Date: 2010-04-10 Impact factor: 3.861

6. B cell depletion for autoimmune diseases in paediatric patients.

Authors: Annette F Jansson; Claudia Sengler; Jasmin Kuemmerle-Deschner; Bernd Gruhn; A Birgitta Kranz; Hartwig Lehmann; Daniela Kleinert; Lars Pape; Hermann J Girschick; Ivan Foeldvari; Dieter Haffner; Johannes P Haas; Dagmar Moebius; Dirk Foell; Joachim Peitz; Veit Grote
Journal: Clin Rheumatol Date: 2010-12-01 Impact factor: 2.980

7. Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.

Authors: Jing Lu Kroll; Craig Beam; Shaobing Li; Raphael Viscidi; Bonnie Dighero; Alice Cho; David Boulware; Mark Pescovitz; Adriana Weinberg
Journal: J Clin Virol Date: 2013-02-17 Impact factor: 3.168

8. Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy.

Authors: Akinao Okamoto; Akihiro Abe; Masataka Okamoto; Tsukane Kobayashi; Tomohiko Terazawa; Yoko Inaguma; Masutaka Tokuda; Masamitsu Yanada; Satoko Morishima; Tadaharu Kanie; Yukiya Yamamoto; Motohiro Tsuzuki; Yoshiki Akatsuka; Shuichi Mizuta; Tetsushi Yoshikawa; Nobuhiko Emi
Journal: Int J Hematol Date: 2012-08-18 Impact factor: 2.490

9. Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.

Authors: Yin-Hua Wang; Lei Fan; Li Wang; Run Zhang; Ji Xu; Cheng Fang; Jian-Yong Li; Wei Xu
Journal: Support Care Cancer Date: 2012-11-15 Impact factor: 3.603

10. Rapidly fatal Acanthamoeba encephalitis and treatment of cryoglobulinemia.

Authors: Wouter Meersseman; Katrien Lagrou; Raf Sciot; Johan de Jonckheere; Christine Haberler; Julia Walochnik; Willy E Peetermans; Eric van Wijngaerden
Journal: Emerg Infect Dis Date: 2007-03 Impact factor: 6.883